SLXN · Company research

Silexion Therapeutics Corp Ordinary Shares (SLXN): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

15records availableHealthcare

Stock News & Events data

Database-backed records only

15 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Most Active US Stocks Today: SLND, SLXN, BKYI, SDEV Among Busiest Names - ChartMillMost Active US Stocks Today: SLND, SLXN, BKYI, SDEV Among Busiest Names ChartMillView source ↗ChartMillOct 15, 2026neutral00.6
SLXN Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Lower - EPS Miss Report - https://www.dars.gov.et/SLXN Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Lower - EPS Miss Report https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Oct 8, 2026neutral00.6
Silexion Therapeutics Announces Warrant Inducement Financing Deal - The Globe and MailSilexion Therapeutics Announces Warrant Inducement Financing Deal The Globe and MailView source ↗The Globe and MailSep 30, 2026neutral00.6
Silexion Therapeutics (SLXN) Stock Soars 61% After Hours: Here's What's Going On - BenzingaSilexion Therapeutics (SLXN) Stock Soars 61% After Hours: Here's What's Going On BenzingaView source ↗BenzingaSep 29, 2026neutral00.6
Silexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice - The Globe and MailSilexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice The Globe and MailView source ↗The Globe and MailSep 26, 2026neutral00.6
Price to sales forward of Silexion Therapeutics Corp – NASDAQ:SLXN - TradingViewPrice to sales forward of Silexion Therapeutics Corp – NASDAQ:SLXN TradingViewView source ↗TradingViewSep 26, 2026neutral00.6
(SLXN) and the Role of Price-Sensitive Allocations - Stock Traders Daily(SLXN) and the Role of Price-Sensitive Allocations Stock Traders DailyView source ↗Stock Traders DailyJul 4, 2026neutral00.6
SLXN Forecast — Price Target — Prediction for 2027 - TradingViewSLXN Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Silexion Therapeutics Announces 1-for-10 Reverse Share Split - GlobeNewswireSilexion Therapeutics Announces 1-for-10 Reverse Share Split GlobeNewswireView source ↗GlobeNewswireMay 26, 2026neutral00.6
Silexion Therapeutics (SLXN) spikes as investors react to mid-May clinical-trial milestones and fresh financing - Quiver QuantitativeSilexion Therapeutics (SLXN) spikes as investors react to mid-May clinical-trial milestones and fresh financing Quiver QuantitativeView source ↗Quiver QuantitativeMay 20, 2026neutral00.6
Biotech Stock Silexion Therapeutics Corp. (NASDAQ: SLXN) Soars on Update and First Quarter Results - Investorideas.comBiotech Stock Silexion Therapeutics Corp. (NASDAQ: SLXN) Soars on Update and First Quarter Results Investorideas.comView source ↗Investorideas.comMay 20, 2026neutral00.6
Traders are paying attention to the gapping stocks in Wednesday's session. - ChartMillTraders are paying attention to the gapping stocks in Wednesday's session. ChartMillView source ↗ChartMillMay 20, 2026neutral00.6
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMillStay updated with the stocks that are on the move in today's pre-market session. ChartMillView source ↗ChartMillMay 20, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNAug 17, 2024neutral00.6
Silexion Therapeutics Corp (SLXN) Stock Price, News, Quote & History - Yahoo! Finance CanadaSilexion Therapeutics Corp (SLXN) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaAug 16, 2024neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.